ERBB2 and breast cancer: Reviewing the relationship between partial dormancy factors and WNT signaling, PAQR8 expression has been shown to reduce WNT1 activity in HER2+ breast cancer models, while the loss of NR2F1 activates WNT signaling and subsequently inhibits E-cadherin expression.